Bio Path Stock Target Price and Analyst Consensus
| BPTH Stock | USD 0.82 0.02 2.50% |
The current analyst and expert consensus on Bio Path is Buy, with no strong buy opinions. The current projected Bio Path target price consensus is 12.00 with 1 analyst opinions. Check out Macroaxis Advice on Bio Path to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Bio Path Holdings analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Bio Path executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Bio Path. We encourage you to use your own analysis of Bio Path Holdings to validate this buy or sell advice. Bio Path buy-or-sell recommendation module provides average expert sentiment on the projected Bio Path Holdings target price to derive its highest and lowest estimates based on projected price volatility of 6.8525.
Lowest Forecast 10.92 | Highest Forecast 13.32 | Target Price 12 |
Bio |
It's important to approach Bio Path's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Bio Path price targets
Bio Path's stock target price is an estimate of its future price, usually made by analysts. Using Bio Path's target price to determine if it is a suitable investment can be done through the following steps:- Look at Bio Path's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Bio Path's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Bio Path Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Bio Path is a key component of Bio Path valuation and have some predictive power on the future returns of a Bio Path.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Path's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Business Services Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | FinTech Invested over 40 shares | |
 | Investor Favorites Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Manufacturing Invested over 30 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Momentum Invested few shares |
Check out Macroaxis Advice on Bio Path to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.